Fight Aging! Newsletter, September 3rd 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is published under the Creative Commons Attribution 4.0 International License. You are encouraged to republish and rewrite it in any way you see fit, the only requirements being that you provide attribution and a link to Fight Aging! To subscribe or unsubscribe please visit: https://www.fightaging.org/newsletter/ Contents An Examination of the Link Between Chronic Inflammation and Cognitive Decline First Generation Pharmaceutical Treatments for Transthyretin Amyloidosis Continue to Make Progress The Futility of Attempts to Rigorously Distinguish Age-Related Disease from Aging The State of Evidence for a Novel TP53-DHEAS Anti-Cancer Mechanism in Primates Cellular Senescence is One of the Causes of Age-Related Decline of Liver Regeneration An Update on a Human Telomerase and Follistatin Gene Therapy Mitochondrial Mechanisms Link ...
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part AAuthor(s): Zhongyi Zhang, Wen-Xiong Wang, Nengjian Zheng, Yansheng Cao, Hongwei Xiao, Renguo Zhu, Hui Guan, Huayun Xiao
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Publication date: January 2021Source: Safety Science, Volume 133Author(s): Helen Lingard, Tracy Cooke, Greg Zelic, James Harley
Authors: Sabet Sarvestani F, Azarpira N Abstract Heart and cerebral infarctions, as two important ischemic diseases, lead to the death of tissues due to inadequate blood supply and high mortality worldwide. These statuses are started via blockage of vessels and depletion of oxygen and nutrients which affected these areas. After reperfusion and restoration of oxygen supply, more severe injury was mediated by multifaceted cascades of inflammation and oxidative stress. microRNAs (miRNAs) as the regulator of biological and pathological pathways can adjust these conditions by interaction with their targets. Also, miRNAs...
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Publication date: Available online 9 October 2020Source: Cirugía Española (English Edition)Author(s): Victoria Lucas-Guerrero, Mireia Pascua-Solé, José Luis Ramos Rodríguez, Anna Trinidad Borrás, Carlos González de Pedro, José María Jover Navalón, Pere Rebasa, Eduardo M. Targarona Soler, Xavier Serra-Aracil, on behalf of the Comisión Nacional de la Especialidad de Cirugía General y del Aparato Digestivo, de la Sección de Formación de la Asociación Española de Cirujanos
More News: African Health | Alzheimer's | Amyloidosis | Anxiety | Argentina Health | Arteriosclerosis | Australia Health | Back Pain | Biochemistry | Biology | Biotechnology | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | Cardiomyopathy | Cardiovascular | Chemistry | Child Development | Children | China Health | Chronic Kidney Disease | Chronic Pain | Clinical Trials | Conferences | Diabetes | Disability | Education | Endocrinology | Environmental Health | Food and Drug Administration (FDA) | Funding | Fundraising | Gastroschisis Repair | Gene Therapy | Genetics | Government | Grants | Heart | Heart Attack | Heart Disease | Heart Failure | Heart Transplant | Hospitals | Hyperactivity | Hypermetropia (long sighted) | Ibuprofen | Immunotherapy | Insect Bites & Stings | Insulin | Ischemic Stroke | Jobs | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Legislation | Lessons | Liver | Liver Disease | Liver Transplant | Medical Ethics | Medical Law | Men | Menopause | Mitochondria | Mitochondrial Disease | Molecular Biology | Netherlands Health | Neurology | Neuroscience | Orthopaedics | Osteoarthritis | Ovarian Cancer | Ovaries | Pain | Parkinson's Disease | Pathology | Perfusion | Pfizer | Politics | Rare Diseases | Reproduction Medicine | Research | Russia Health | Science | Skin | Smokers | Spain Health | Stem Cell Therapy | Stem Cells | Stroke | Study | Transplants | UK Health | Universities & Medical Training | Urology & Nephrology | USA Health | Venezuela Health